APA (7th ed.) Citation

K, H., RM, E. T., ZW, E., AM, Y., A, H., AM, E., . . . A, O. (2026). Efficacy of pegfilgrastim in preventing febrile neutropenia during DCF chemotherapy for esophageal cancer: A systematic review and meta-analysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 10781552261416090. https://doi.org/10.1177/10781552261416090

Chicago Style (17th ed.) Citation

K, Hemdan, El Tabakh RM, Elmezayen ZW, Yousef AM, Hussein A, Elghareab AM, Shehata MM, Ellethey AA, and Oun A. "Efficacy of Pegfilgrastim in Preventing Febrile Neutropenia During DCF Chemotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 2026: 10781552261416090. https://doi.org/10.1177/10781552261416090.

MLA (9th ed.) Citation

K, Hemdan, et al. "Efficacy of Pegfilgrastim in Preventing Febrile Neutropenia During DCF Chemotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, 2026, p. 10781552261416090, https://doi.org/10.1177/10781552261416090.